Stephen J Rossi
NGM Biopharmaceuticals, Inc · Gilead Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stephen J Rossi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02704364 · A Study of NGM282 in Patients With Primary Sclerosing CholangitisNGM Biopharmaceuticals, Inc · completed · Primary Sclerosing Cholangitis · study director
- Ph1/Ph2NCT02649062 · Study of NGM282 in Subjects With Functional Constipation and Healthy IndividualsNGM Biopharmaceuticals, Inc · completed · Functional Constipation · study director
- Ph2NCT02135536 · Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary CirrhosisNGM Biopharmaceuticals, Inc · completed · Primary Biliary Cirrhosis · study director
- Ph2NCT02026401 · Phase 2 Study of NGM282 in Patients With Primary Biliary CirrhosisNGM Biopharmaceuticals, Inc · completed · Primary Biliary Cirrhosis · study director
- Ph2NCT00307489 · Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir DipivoxilGilead Sciences · completed · Chronic Hepatitis B · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:37 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- 356 citationsRCR 13.5
- NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.Hepatology · 2020214 citationsRCR 10.0
- 169 citationsRCR 7.3
- A comparison of periodization models during nine weeks with equated volume and intensity for strength.J Strength Cond Res · 200775 citationsRCR 2.8
- Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.J Hepatol · 201975 citationsRCR 2.8
- Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation.Ann Thorac Surg · 199749 citationsRCR 1.7
- Efficacy and safety of peginterferon alfa-2a/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration.Am J Gastroenterol · 200834 citationsRCR 0.9
- Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial.Am J Gastroenterol · 201831 citationsRCR 1.2
- Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.Transplant Proc · 19996 citationsRCR 0.3
- Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.Transplant Proc · 19996 citationsRCR 0.3